Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment.
about
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotics for ureaplasma in the vagina in pregnancyAntibiotics for ureaplasma in the vagina in pregnancyChlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and AsiaThe APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysisInterventions for treating genital chlamydia trachomatis infection in pregnancy.Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality.Vaginal and oral microbes, host genotype and preterm birthComparison of PCR, nested PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women.Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocolAerobic vaginitis in pregnancy.Racial disparities in preterm births. The role of urogenital infections.Quantitative microbiologic models for preterm deliveryThe frequent shift to intermediate flora in preterm delivery cases after abnormal vaginal flora screening.Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results.Demographic, clinical and microbiological characteristics of maternity patients: a Canadian clinical cohort studyRandomized, double-blinded, placebo-controlled trial of amoxicillin/clavulanic acid to prevent preterm delivery in twin gestation.Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage.Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection.Endogenous bacterial flora in pregnant women and the influence of maternal genetic variation.Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study.Management of preterm prelabour rupture of membranes: an audit. How do the results compare with clinical practice guidelines?Infection and inflammation.Erythromycin treatment of pregnant women to reduce the incidence of low birth weight and preterm deliveries.Interventions for treating genital Chlamydia trachomatis infection in pregnancy.Screening for genital chlamydia infectionBacterial vaginosis
P2860
Q24186506-57B13789-8913-429F-914B-2FEFFBD759D9Q24187066-108BE9F0-1741-43E7-A37F-C56743B254E1Q24234256-71763DB9-0A0F-4726-A368-197E4A95DD31Q24247442-749A89B0-E8BE-487B-9AF3-C35AEA137DECQ26752829-01C785EC-0D38-4F31-84E6-81F5D703F7B4Q28471972-D251523A-392F-4895-96CA-B7EC6F9DEA65Q30867300-D7C2A33A-74F0-4D2F-B58C-01E0E3D4E3BEQ30879958-E268AD82-9A81-4989-939D-485FCA31E6BDQ33631535-2EC48D1B-8573-4D6A-814B-F04DCBC381DBQ33679411-E12F3A73-D1E6-4F96-AD16-EC60F3BCD5E6Q34025678-4A6F8EDE-EFAF-408E-A17E-2CD4DB6515C8Q34192094-25F34F63-42BE-449E-86E4-877B8B725381Q34404331-09443980-7AC4-4413-AE47-89F2C155D580Q34774440-467D01DC-9F2F-4531-BCEC-AA7614D55307Q35156830-68BDD31F-2154-4A15-AAB5-A597A9BD5AFFQ35531854-11CD0FD8-456A-44CA-941F-9239EA3DA4C2Q35690055-8326254A-CDFB-4844-B1A0-F542FE5ABA61Q36170606-500B2B58-E855-45D7-A269-9EC713DC6080Q36624891-E7CD08ED-C5D3-4760-BD9C-DF069665FC63Q36884012-BB00B2B3-6B96-4AB5-95FB-F3326F35A1D1Q37345675-D2422229-B0FA-4ADB-8BD3-491C9D3A118AQ37807518-FAB58384-C543-4414-B3F5-1CA8CA6B8ADCQ37836433-0316C725-F024-4E6E-9FE5-B079F78634A7Q37854781-EFDADD44-AEE2-4097-9670-00D4B1D2E9ABQ46498833-90F190F6-D1C2-445A-9673-C59F828FD2C3Q46793498-2B155F11-529C-44D6-86BF-F512D76742E3Q47282377-327C39F3-BC56-46DE-A324-BCF4EE981743Q51795966-21B119B6-7EA3-4763-BD53-78CC7DFC5D93Q55491238-1280C284-BC52-4D2D-9614-77963D515FF2Q57657414-CA47A33B-0D9A-4CC1-880C-14F82A933CCD
P2860
Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@en
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@nl
type
label
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@en
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@nl
prefLabel
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@en
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@nl
P2093
P1476
Cervicovaginal microflora and ...... ial of erythromycin treatment.
@en
P2093
McGregor JA
Schoonmaker J
Vuchetich M
P304
P356
10.1016/0002-9378(90)90632-H
P407
P433
P577
1990-11-01T00:00:00Z